Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Memantine hydrochloride 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Memantine hydrochloride (substance) |
Inferred relationship |
Some |
|
Memantine hydrochloride 10mg/g oral drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Memantine hydrochloride (substance) |
Inferred relationship |
Some |
|
Product containing memantine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Memantine hydrochloride (substance) |
Inferred relationship |
Some |
|
Memantine hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Memantine hydrochloride (substance) |
Inferred relationship |
Some |
|
Memantine 2mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Memantine hydrochloride (substance) |
Inferred relationship |
Some |
|
Product containing precisely memantine hydrochloride 21 milligram/1 each prolonged-release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Memantine hydrochloride (substance) |
Inferred relationship |
Some |
|
Memantine hydrochloride 28 mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Memantine hydrochloride (substance) |
Inferred relationship |
Some |
|
Memantine hydrochloride 14 mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Memantine hydrochloride (substance) |
Inferred relationship |
Some |
|
Memantine hydrochloride 7 mg prolonged-release oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Memantine hydrochloride (substance) |
Inferred relationship |
Some |
|
Memantine hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Memantine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Memantine hydrochloride 10 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Memantine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Memantine hydrochloride 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Memantine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Memantine hydrochloride 5 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Memantine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Memantine hydrochloride 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Memantine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Memantine hydrochloride 5 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Memantine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely memantine hydrochloride 21 milligram/1 each prolonged-release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Memantine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely memantine hydrochloride 21 milligram/1 each prolonged-release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Memantine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Memantine hydrochloride 28 mg prolonged-release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Memantine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Memantine hydrochloride 28 mg prolonged-release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Memantine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Memantine hydrochloride 7 mg prolonged-release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Memantine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Memantine hydrochloride 7 mg prolonged-release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Memantine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Memantine hydrochloride 14 mg prolonged-release oral capsule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Memantine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Memantine hydrochloride 14 mg prolonged-release oral capsule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Memantine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Memantine hydrochloride 2 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Memantine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Memantine hydrochloride 2 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Memantine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Memantine hydrochloride 20 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Memantine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Memantine hydrochloride 20 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Memantine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Donepezil (as donepezil hydrochloride) 5 mg and memantine (as memantine hydrochloride) 10 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Memantine hydrochloride (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely memantine hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Memantine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely memantine hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Memantine hydrochloride (substance) |
Inferred relationship |
Some |
1 |